Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /ADIA
chevron_leftBack
Adia Nutrition, Inc. logo

Adia Nutrition, Inc.

ADIA
OTCMKTS: ADIA Delayed
0.1890USD 0%
As of 15 June 2026, Adia Nutrition, Inc. has a market cap of $17.84M USD, ranking #37874 globally and #5056 in the United States. It ranks #3378 in the Healthcare sector, and #212 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
37874
Country Rank
5056
Sector Rank
3378
Industry Rank
212
Key Stats
Market Cap
$17.84MUSD
Enterprise Value
$18.72MUSD
Revenue (TTM)
$700.51KUSD
EBITDA (TTM)
-$338.23KUSD
Net Income (TTM)
-$395.46KUSD
EBITDA Margin
-48%
Profit Margin
-56%
PS Ratio
25.5
PB Ratio
-69.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Larry Powalisz open_in_new
Employees
3
Founded
1999
Website
adianutrition.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -5.5% 58% -0.5% 397% 244%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
ADIA
Adia Nutrition Inc
ISIN: US00687W1099
TV:
SA:
YF:
GF:
BA:
MS:
0.1890 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Adia Nutrition, Inc.

Adia Nutrition, Inc. offers medical treatments and nutritional supplements. It operates in three segments: Biolete, Adia Med, and Adia Labs. The company provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. It also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as PivX Solutions Inc. and changed its name to Adia Nutrition, Inc. in May 2004. Adia Nutrition, Inc. is based in Winter Park, Florida.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
PE
$29.56B
166K%
-
INDV
$2.07B
1.54B GBP
11K%
-
NDOI
$1.8B
10K%
0.4
$1.76B
10K%
-
$1.33B
7K%
-
$1.02B
6K%
12.1
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.29B
108.92B ILS
209K%
24.2
$15.86B
107.34B CNY
89K%
16.0
CIPLA
$11.17B
1.06T INR
63K%
23.4
LUPIN
$11.05B
1.05T INR
62K%
22.7
$9.1B
61.6B CNY
51K%
80.6
$8.74B
7.57B EUR
49K%
-
chevron_leftBack